Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2022

View Archived Issues

Elamipretide potentiates dystrophin expression induced by PMO in a murine model of DMD

Johns Hopkins University and IOCB of the ASCR patent 6-MP prodrugs

Researchers describe new ghrelin receptor GHSR1a ligand to modulate brain dopamine

Removal of S protein glycan shields yields broadly protective SARS-CoV-2 vaccine

Novel mesothelin-targeted TriKE antibody against NSCLC

WTX-124, a conditionally activated IL-2 prodrug with minimized toxicity in cancer models

Ceftibuten/VNRX-7145 shows efficacy against Enterobacterales carrying common serine beta-lactamases

Food-borne bacterium's neuroinvasion mechanism discovered

3,6'-Dithiopomalidomide shows promise for treating AD

Soligenix reports CiVax booster vaccination findings

NexImmune partners with Zephyr AI to discover novel targets for T-cell-mediated therapies for cancer

Roche patents new compounds for SARS-CoV-2 infection

Valorisation-Recherche discloses IL-1 inhibitors

Incyte presents GTPase KRAS mutant inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...